Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             44 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice Basso, B
 2004
 22 15-16 p. 1868-1872
5 p.
 artikel
2 A global perspective on vaccine safety Duclos, Philippe
 2004
 22 15-16 p. 2059-2063
5 p.
 artikel
3 Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes Schutze-Redelmeier, Marie-Paule M
 2004
 22 15-16 p. 1985-1991
7 p.
 artikel
4 A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4 Evans, Jay T
 2004
 22 15-16 p. 1964-1972
9 p.
 artikel
5 Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination Ovsyannikova, Inna G
 2004
 22 15-16 p. 1914-1920
7 p.
 artikel
6 Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old Chokephaibulkit, Kulkanya
 2004
 22 15-16 p. 2018-2022
5 p.
 artikel
7 Chimpanzees and journalists Plotkin, Stanley A
 2004
 22 15-16 p. 1829-1830
2 p.
 artikel
8 Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study Hung, Chien-Ching
 2004
 22 15-16 p. 2006-2012
7 p.
 artikel
9 Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity Xu, Gaoyuan
 2004
 22 15-16 p. 1846-1853
8 p.
 artikel
10 Control without separate controls: evaluation of vaccine safety using case-only methods Farrington, C.P
 2004
 22 15-16 p. 2064-2070
7 p.
 artikel
11 Development of a hemi-nested RT-PCR method for the specific determination of European Bat Lyssavirus 1 Picard-Meyer, E
 2004
 22 15-16 p. 1921-1929
9 p.
 artikel
12 Distribution of adsorbed antigen in mono-valent and combination vaccines Morefield, Garry L.
 2004
 22 15-16 p. 1973-1984
12 p.
 artikel
13 Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model David, Silke
 2004
 22 15-16 p. 1892-1898
7 p.
 artikel
14 Ethical aspects of the methods used to evaluate the safety of vaccines Spier, R.E
 2004
 22 15-16 p. 2085-2090
6 p.
 artikel
15 Evaluation of diphtheria convalescent patients to serve as donors for the production of anti-diphtheria immunoglobulin preparations Bissumbhar, B
 2004
 22 15-16 p. 1886-1891
6 p.
 artikel
16 Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies Chen, Robert T.
 2004
 22 15-16 p. 2047-2053
7 p.
 artikel
17 Field evaluation of vaccine safety Tozzi, Alberto E
 2004
 22 15-16 p. 2091-2095
5 p.
 artikel
18 Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1 Gogev, Sacha
 2004
 22 15-16 p. 1946-1953
8 p.
 artikel
19 HIV risk and prevention in a post-vaccine context Newman, Peter A
 2004
 22 15-16 p. 1954-1963
10 p.
 artikel
20 Hospitalisations for gastroenteritis: the role of rotavirus Rivest, Paul
 2004
 22 15-16 p. 2013-2017
5 p.
 artikel
21 Humoral immunoreaction induced by TCR DNA vaccine for β chain of T cell lymphoma Zhang, Mingzhi
 2004
 22 15-16 p. 2031-2041
11 p.
 artikel
22 IFC 2004
 22 15-16 p. IFC-
1 p.
 artikel
23 Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines Wang, Xuan-Yi
 2004
 22 15-16 p. 1941-1945
5 p.
 artikel
24 Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis Zadeh-Vakili, Azita
 2004
 22 15-16 p. 1930-1940
11 p.
 artikel
25 Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli Oliveira-Ferreira, Joseli
 2004
 22 15-16 p. 2023-2030
8 p.
 artikel
26 Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition Foged, Camilla
 2004
 22 15-16 p. 1903-1913
11 p.
 artikel
27 Intracellular fate and immunogenicity of B. subtilis spores Duc, Le H
 2004
 22 15-16 p. 1873-1885
13 p.
 artikel
28 Itching nodules and hypersensitivity to alminium after the use of adsorbed vaccines from SSI Thierry-Carstensen, Birgit
 2004
 22 15-16 p. 1845-
1 p.
 artikel
29 Material deprivation, hospitalisation and adverse events temporally associated with immunisation Olowokure, Babatunde
 2004
 22 15-16 p. 1842-1844
3 p.
 artikel
30 Methodological issues arising from systematic reviews of the evidence of safety of vaccines Price, D
 2004
 22 15-16 p. 2080-2084
5 p.
 artikel
31 Obituary: Fred Brown Spier, R.E
 2004
 22 15-16 p. 1827-1828
2 p.
 artikel
32 Oral polio vaccine: fact versus fiction Osterrieth, Paul
 2004
 22 15-16 p. 1831-1835
5 p.
 artikel
33 Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands) Postma, M.J
 2004
 22 15-16 p. 1862-1867
6 p.
 artikel
34 Technologies that make administration of vaccines safer Clements, C.John
 2004
 22 15-16 p. 2054-2058
5 p.
 artikel
35 The Brighton Collaboration—enhancing vaccine safety Bonhoeffer, Jan
 2004
 22 15-16 p. 2046-
1 p.
 artikel
36 The Cochrane Vaccines Field Barale, Antonella
 2004
 22 15-16 p. 2044-2045
2 p.
 artikel
37 The evidence for the safety of thiomersal in newborn and infant vaccines Clements, C.John
 2004
 22 15-16 p. 1854-1861
8 p.
 artikel
38 The First International Symposium on Vaccine Safety Demicheli, Vittorio
 2004
 22 15-16 p. 2042-2043
2 p.
 artikel
39 The prevalence of anti-rubella antibodies in women of childbearing age in Poland Wysokiñska, T.
 2004
 22 15-16 p. 1899-1902
4 p.
 artikel
40 The role of editorial peer review in the evaluation of vaccine safety Jefferson, Tom
 2004
 22 15-16 p. 2073-2075
3 p.
 artikel
41 The societal value of universal childhood vaccination Chabot, Isabelle
 2004
 22 15-16 p. 1992-2005
14 p.
 artikel
42 The success of immunization—shovelling its own grave? Heininger, Ulrich
 2004
 22 15-16 p. 2071-2072
2 p.
 artikel
43 Thiomersal in vaccines: a regulatory perspective Knezevic, I
 2004
 22 15-16 p. 1836-1841
6 p.
 artikel
44 Use of vaccine surveillance data in the evaluation of safety of vaccines Postila, Ville
 2004
 22 15-16 p. 2076-2079
4 p.
 artikel
                             44 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland